Thursday, November 2, 2023

CVS Health: Goldman Sachs reduces the target price from USD 89 to USD 86.

  maintains its buy recommendation

https://www.marketscreener.com/quote/stock/CVS-HEALTH-CORPORATION-12230/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.